A substantial amount of data indicates that an anti-IL-13 vaccine may be beneficial for the prevention of the amelioration of hepatic fibrosis in Schistosoma infection [68] as well as non-infectious fibrosis, as reported in many studies (see above) [69,70,71]. The gene discussed is IL13; the disease is Hepatic fibrosis.